An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma.
暂无分享,去创建一个
M. Linder | M. Monopoli | U. Kauscher | M P Monopoli | M S Grunér | U Kauscher | M B Linder | M. Grunér
[1] H. Bayır,et al. Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes In Vitro and In Vivo , 2009, PloS one.
[2] Kenneth A. Dawson,et al. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.
[3] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[4] M. Rillig. A connection between fungal hydrophobins and soil water repellency , 2005 .
[5] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[6] Istvan Toth,et al. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.
[7] Minnamari Vippola,et al. Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. , 2011, ACS nano.
[8] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[9] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[10] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[11] Kenneth A. Dawson,et al. Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma , 2012, PloS one.
[12] Merja Penttilä,et al. Atomic Resolution Structure of the HFBII Hydrophobin, a Self-assembling Amphiphile* , 2004, Journal of Biological Chemistry.
[13] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[14] Katia Perruccio,et al. Surface hydrophobin prevents immune recognition of airborne fungal spores , 2009, Nature.
[15] Hak Soo Choi,et al. Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.
[16] G. Cannon,et al. Adsorption of a Fungal Hydrophobin Onto Surfaces as Mediated by the Associated Polysaccharide Schizophyllan , 1999 .
[17] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[18] Merja Penttilä,et al. Surface adhesion of fusion proteins containing the hydrophobins HFBI and HFBII from Trichoderma reesei , 2002, Protein science : a publication of the Protein Society.
[19] M. Tolomeo,et al. Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one. , 2015, European journal of medicinal chemistry.
[20] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[21] Wolfgang J Parak,et al. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.
[22] P. Laaksonen,et al. Self-assembly of class II hydrophobins on polar surfaces. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[23] Giulio Caracciolo,et al. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[24] Juha Rouvinen,et al. Crystallization and preliminary X-ray characterization of Trichoderma reesei hydrophobin HFBII. , 2004, Acta crystallographica. Section D, Biological crystallography.
[25] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[26] H. Wösten,et al. Role of proteins in soil carbon and nitrogen storage: controls on persistence , 2007 .
[27] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[28] Claus-Michael Lehr,et al. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. , 2012, ACS nano.
[29] H. Santos,et al. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. , 2012, Molecular pharmaceutics.
[30] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[31] Juha Rouvinen,et al. Two crystal structures of Trichoderma reesei hydrophobin HFBI—The structure of a protein amphiphile with and without detergent interaction , 2006, Protein science : a publication of the Protein Society.
[32] W. Kreyling,et al. The influence of pulmonary surfactant on nanoparticulate drug delivery systems. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[33] Jau-Song Yu,et al. Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. , 2011, Analytical biochemistry.
[34] M. Penttilä,et al. The hydrophobins HFBI and HFBII from Trichoderma reesei showing efficient interactions with nonionic surfactants in aqueous two-phase systems. , 2001, Biomacromolecules.
[35] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[36] M. Linder,et al. Hydrophobins: Proteins that self assemble at interfaces , 2009 .
[37] Giulio Caracciolo,et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.
[38] K. Dawson,et al. The protein corona of dendrimers: PAMAM binds and activates complement proteins in human plasma in a generation dependent manner , 2012 .
[39] D. L. Cooper,et al. High-resolution sizing of monolayer-protected gold clusters by differential centrifugal sedimentation. , 2013, ACS nano.
[40] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[41] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[42] Molly M. Stevens,et al. Emerging techniques for submicrometer particle sizing applied to Stöber silica. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[43] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[44] Giulio Caracciolo,et al. Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients. , 2014, Colloids and surfaces. B, Biointerfaces.
[45] Tiina Nakari-Setälä,et al. Hydrophobins: the protein-amphiphiles of filamentous fungi. , 2005, FEMS microbiology reviews.
[46] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[47] James L. McGrath,et al. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.
[48] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[49] Pauline M Rudd,et al. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions. , 2015, ACS nano.
[50] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.